Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kane

Showing results (881-890 of 1,451) with videos related to

Pageof 146
Sort By:
Hospital Pediatrics|September 28, 2025
Impact of Body Mass Index on Adverse Events in Children Undergoing Sedation for MRIJaimee S Holbrook, Jason M Kane, Mei Han, et al.
Therapeutic Advances in Psychopharmacology|March 9, 2026
Plain Language Summary of Publication: What experts agree about using long-acting injectable antipsychotic medicine for people early in their experience of schizophreniaAndrea Fagiolini, Murat Yildirim, Celso Arango, et al.
The American Journal of Psychiatry|August 6, 2003
Clozapine as a first treatment for schizophreniaMargaret G Woerner, Delbert G Robinson, Jose Ma J Alvir, et al.
The Journal of Clinical Psychiatry|July 1, 1988
Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugsJ A Lieberman, C A Johns, J M Kane, et al.
CNS Drugs|March 29, 2012
Ziprasidone and the corrected QT interval: a comprehensive summary of clinical dataA John Camm, Onur N Karayal, Herbert Meltzer, et al.
Frontiers in Psychiatry|August 9, 2014
Abnormal Parietal Brain Function in ADHD: Replication and Extension of Previous EEG Beta Asymmetry FindingsT Sigi Hale, Andrea M Kane, Kelly L Tung, et al.
The American Surgeon|November 30, 2017
Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB MelanomaMoshim Kukar, Emmanuel Gabriel, Rebecca May, et al.
Frontiers in Dementia|July 31, 2024
Developing a person-centered stated preference survey for dementia with Lewy bodies: value of a personal and public involvement processPaula Sinead Donnelly, Aoife Sweeney, Emily Wilson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 25, 2019
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important differenceMark Stacy, Martha Sajatovic, John M Kane, et al.
The American Journal of Psychiatry|November 3, 2010
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)Brian L Strom, Sybil M Eng, Gerald Faich, et al.
Pageof 146

Showing results (881-890 of 1,451) with videos related to

Sort By:
Pageof 146
Hospital Pediatrics|September 28, 2025
Impact of Body Mass Index on Adverse Events in Children Undergoing Sedation for MRIJaimee S Holbrook, Jason M Kane, Mei Han, et al.
Therapeutic Advances in Psychopharmacology|March 9, 2026
Plain Language Summary of Publication: What experts agree about using long-acting injectable antipsychotic medicine for people early in their experience of schizophreniaAndrea Fagiolini, Murat Yildirim, Celso Arango, et al.
The American Journal of Psychiatry|August 6, 2003
Clozapine as a first treatment for schizophreniaMargaret G Woerner, Delbert G Robinson, Jose Ma J Alvir, et al.
The Journal of Clinical Psychiatry|July 1, 1988
Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugsJ A Lieberman, C A Johns, J M Kane, et al.
CNS Drugs|March 29, 2012
Ziprasidone and the corrected QT interval: a comprehensive summary of clinical dataA John Camm, Onur N Karayal, Herbert Meltzer, et al.
Frontiers in Psychiatry|August 9, 2014
Abnormal Parietal Brain Function in ADHD: Replication and Extension of Previous EEG Beta Asymmetry FindingsT Sigi Hale, Andrea M Kane, Kelly L Tung, et al.
The American Surgeon|November 30, 2017
Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB MelanomaMoshim Kukar, Emmanuel Gabriel, Rebecca May, et al.
Frontiers in Dementia|July 31, 2024
Developing a person-centered stated preference survey for dementia with Lewy bodies: value of a personal and public involvement processPaula Sinead Donnelly, Aoife Sweeney, Emily Wilson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 25, 2019
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important differenceMark Stacy, Martha Sajatovic, John M Kane, et al.
The American Journal of Psychiatry|November 3, 2010
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)Brian L Strom, Sybil M Eng, Gerald Faich, et al.
Pageof 146